Why the study?
Does diabetes increase the risk of cardiovascular events in the Framingham cohort?
Population
Framingham cohort
Comparison
Prior evidence of diabetes vs Nondiabetic
Design
Cohort
Follow-up
20 years
Authors
Loading...
Supports targeted surveillance for claudication and HF in diabetes; extends classic cohort data but leaves causal effects open.
Does diabetes increase the risk of cardiovascular events in the Framingham cohort?
Diabetes confers a 2- to 3-fold increased risk of clinical atherosclerotic disease, with a particularly pronounced relative impact on cardiovascular mortality and heart failure in women.
William B. Kannel (1979) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: